165 related articles for article (PubMed ID: 24576472)
1. Immunity against poliomyelitis in the Netherlands, assessed in 2006 to 2007: the importance of completing a vaccination series.
van der Maas NA; Mollema L; Berbers GA; van Rooijen DM; van der Avoort HG; Conyn-Van Spaendonck MA; de Melker HE; van der Klis FR
Euro Surveill; 2014 Feb; 19(7):20705. PubMed ID: 24576472
[TBL] [Abstract][Full Text] [Related]
2. Seroprevalence of poliovirus antibodies amongst children in Zaria, Northern Nigeria.
Giwa FJ; Olayinka AT; Ogunshola FT
Vaccine; 2012 Nov; 30(48):6759-65. PubMed ID: 23000220
[TBL] [Abstract][Full Text] [Related]
3. Immunity to poliomyelitis in The Netherlands.
Conyn-Van Spaendonck MA; de Melker HE; Abbink F; Elzinga-Gholizadea N; Kimman TG; van Loon T
Am J Epidemiol; 2001 Feb; 153(3):207-14. PubMed ID: 11157405
[TBL] [Abstract][Full Text] [Related]
4. Mass vaccination campaigns to eradicate poliomyelitis in Madagascar: oral poliovirus vaccine increased immunity of children who missed routine programme.
Andrianarivelo MR; Boisier P; Rabarijaona L; Ratsitorahina M; Migliani R; Zeller H
Trop Med Int Health; 2001 Dec; 6(12):1032-9. PubMed ID: 11737841
[TBL] [Abstract][Full Text] [Related]
5. Poliomyelitis seroprevalence in high risk populations of India before the trivalent-bivalent oral poliovirus vaccine switch in 2016.
Ahmad M; Verma H; Kunwar A; Soni S; Sinha U; Gawande M; Sethi R; Nalavade U; Sharma D; Bhatnagar P; Bahl S; Deshpande J
Int J Infect Dis; 2021 Jan; 102():337-343. PubMed ID: 33130206
[TBL] [Abstract][Full Text] [Related]
6. Seroprevalence of antibody against poliovirus in inner-city preschool children. Implications for vaccination policy in the United States.
Chen RT; Hausinger S; Dajani AS; Hanfling M; Baughman AL; Pallansch MA; Patriarca PA
JAMA; 1996 Jun; 275(21):1639-45. PubMed ID: 8637136
[TBL] [Abstract][Full Text] [Related]
7. Epidemiological serosurvey of poliovirus in Guangdong, China: A cross-sectional study.
Tan Q; Zhu Q; Zheng H; Zhang B; Wu C; Guo X; Li H; Liu L; Liu Y; Rutherford S; Zheng H
Hum Vaccin Immunother; 2018; 14(11):2644-2648. PubMed ID: 30059644
[TBL] [Abstract][Full Text] [Related]
8. A study evaluating poliovirus antibodies and risk factors associated with polio seropositivity in low socioeconomic areas of Pakistan.
Habib M; Soofi S; Ali N; Sutter RW; Palansch M; Qureshi H; Akhtar T; Molodecky NA; Okayasu H; Bhutta ZA
Vaccine; 2013 Apr; 31(15):1987-93. PubMed ID: 23429005
[TBL] [Abstract][Full Text] [Related]
9. Immunity status against poliomyelitis in childbearing women in a province of northern Italy. A cross-sectional analysis.
Veronesi L; Affanni P; Verrotti di Pianella C; Colucci ME; Tanzi ML
Ann Ig; 2013; 25(5):427-33. PubMed ID: 24048181
[TBL] [Abstract][Full Text] [Related]
10. Epidemiological analysis of immunity to poliovirus after termination of an era of vaccination with OPV in Germany. An analysis of the German Association Against Viral Diseases (DVV).
Franck S; Allwinn R; Rabenau HF; Doerr HW
Zentralbl Bakteriol; 1999 Oct; 289(4):475-81. PubMed ID: 10603664
[TBL] [Abstract][Full Text] [Related]
11. Seroprevalence of anti-polio antibodies in a population 7 months to 39 years of age in Uruguay: Implications for future polio vaccination strategies.
Pírez MC; Olivera I; Diabarboure H; Montano A; Barañano R; Badía F; Bonnet MC
Vaccine; 2009 May; 27(20):2689-94. PubMed ID: 19428880
[TBL] [Abstract][Full Text] [Related]
12. Poliovirus antibody levels and lameness among individuals in three regions of Ghana.
Opare JKL; Odoom JK; Akweongo P; Afari EA; Pappoe M
Hum Vaccin Immunother; 2019; 15(9):2050-2059. PubMed ID: 31265356
[No Abstract] [Full Text] [Related]
13. Assessment of seroprevalence against poliovirus among Italian adolescents and adults.
Lupi S; Stefanati A; Baldovin T; Roman A; Baldo V; Gabutti G
Hum Vaccin Immunother; 2019; 15(3):677-682. PubMed ID: 30427738
[TBL] [Abstract][Full Text] [Related]
14. 2001 serological survey in the Czech Republic--poliomyelitis.
Matyásová I; Rainetová P; Cástková J
Cent Eur J Public Health; 2003 Dec; 11 Suppl():S31-5. PubMed ID: 15080257
[TBL] [Abstract][Full Text] [Related]
15. Second national serum bank for population-based seroprevalence studies in the Netherlands.
van der Klis FR; Mollema L; Berbers GA; de Melker HE; Coutinho RA
Neth J Med; 2009; 67(7):301-8. PubMed ID: 19687529
[TBL] [Abstract][Full Text] [Related]
16. Poliovirus neutralizing antibody levels among individuals in three regions of Ghana.
Opare JK; Akweongo P; Afari EA; Odoom JK
Ghana Med J; 2019 Jun; 53(2):170-180. PubMed ID: 31481814
[TBL] [Abstract][Full Text] [Related]
17. Effect on seroprevalence of anti-poliovirus antibodies and on vaccination coverage of the implementation of a DTwP-IPV-Hib vaccination programme in a South American city.
Nates SV; Frias M; Belfiore S; Isa MB; Martinez LC; Chuit R; Armoni J; Luxemburger C
Epidemiol Infect; 2011 Jun; 139(6):826-35. PubMed ID: 20587121
[TBL] [Abstract][Full Text] [Related]
18. A seroprevalence study of poliovirus antibody in the population of northern Greece.
Frantzidou F; Diza E; Halkia D; Antoniadis A
Clin Microbiol Infect; 2005 Jan; 11(1):68-71. PubMed ID: 15649308
[TBL] [Abstract][Full Text] [Related]
19. A seroprevalence study of poliovirus antibody against a collection of recombinant and non-recombinant poliovirus vaccine strains in the population of southern Greece.
Pliaka V; Ruether IG; Kyriakopoulou Z; Kioussi P; Plakokefalos E; Megalou M; Pratti A; Levidiotou-Stefanou S; Markoulatos P
Clin Microbiol Infect; 2010 Nov; 16(11):1672-5. PubMed ID: 20148919
[TBL] [Abstract][Full Text] [Related]
20. Immunity status against poliomyelitis in young migrants: a seroprevalence study.
Veronesi L; Colucci ME; Capobianco E; Bracchi MT; Zoni R; Palandri L; Affanni P
Acta Biomed; 2019 Sep; 90(9-S):28-34. PubMed ID: 31517887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
